Induction docetaxel platinum 5-FU (TPF) followed by cetuximab-radiotherapy (cetux-RT) versus concurrent chemo-radiotherapy (CT/RT) in patients with N2b/c-N3 non operated stage III-IV squamous cell cancer of the head and neck (SCCHN): Results of the GORTEC 2007-02 phase III randomized trial.

被引：19

作者：

Geoffrois, Lionnel

Martin, Laurent

Garaud, Pascal

De Raucourt, Dominique

Miny, Joelle

Maingon, Philippe

Lafond, Cedrik

Tuchais, Claude

Sire, Christian

Babin, Emmanuel

Coutte, Alexandre

Tao, Yungan

Rolland, Frederic

Girard-Calais, Marie Helene

Bourhis, Jean

机构：

[1] Ctr Alexis Vautrin, Vandoeuvre Les Nancy, France

[2] Ctr G Le Conquerant, Radiotherapie, Le Havre, France

[3] GORTEC GETTEC, Tours, France

[4] CAC Caen, Caen, France

[5] Besancon Univ Hosp, Besancon, France

[6] Georges Francois Leclerc Ctr, Dept Radiotherapy, Dijon, France

[7] Clin Victor Hugo, Le Mans, France

[8] Inst Cancerol De Louest Site Paul Papin, Angers, France

[9] CH Bretagne Sud, Lorient, France

[10] CHU Caen, Caen, France

[11] CHU Amiens, Dept Radiotherapie, Amiens, France

[12] Gustave Roussy, Villejuif, France

[13] Ctr Rene Gauducheau, St Herblain, France

[14] CHU Bretonneau, Tours, France

[15] Univ Lausanne, Med Ctr, Lausanne, Switzerland

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期

关键词：

D O I：

10.1200/JCO.2016.34.15_suppl.6000

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

6000

引用

页数：3

共 4 条

[1] Impact of p16 expression on induction taxotere-cisplatin-5 FU (TPF) followed by cetuximab-radiotherapy in N2b-N3 head and neck squamous cell carcinoma (HNSCC): Results of GORTEC 2007-02 phase III randomized trial.
Tao, Yungan
Geoffrois, Lionnel
Martin, Laurent
De Raucourt, Dominique
Miny, Joelle
Maingon, Philippe
Lafond, Cedrik
Tuchais, Claude
Sire, Christian
Babin, Emmanuel
Coutte, Alexandre
Rolland, Frederic
Girard-Calais, Marie-Helene
Casiraghi, Odile
Garaud, Pascal
Bourhis, Jean
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[2] Cetuximab-radiotherapy versus cetuximabradiotherapy plus concurrent chemotherapy in patients with NO-N2a squamous cell carcinoma of the head and neck ( SCCHN): Results of the GORTEC 2007-01 phase III randomized trial.
Bourhis, Jean
Sun, Xu Shan
Sire, Christian
Tao, Yungan
Martin, Laurent
Khoury, Cedric
Maingon, Philippe
Bardet, Etienne
Lapeyre, Michel
Chatellier, Thierry
Ollivier, Nathalie
Cornely, Alexandre
Auperin, Anne
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[3] Mature results of PulmonArt: Involved-field 3D radiotherapy (RT) and docetaxel/cisplatin chemotherapy (CT) in a randomised phase 2 study comparing concurrent CT-RT followed by consolidation CT, with induction CT followed by concurrent CT-RT in patients (pts) with stage III non-small cell lung cancer (NSCLC)
Van Meerbeeck, Jan P.
Cardenal, Felipe
Vansteenkiste, Johan
Stigt, Jos
Fadil, Akyol
De Neve, Wilfried
Bakker, Joke
Dupont, Jean Michel
Scagliotti, Giorgio, V
Senan, Suresh
JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S349 - S350
[4] Cetuximab/radiotherapy (CET plus RT) versus concomitant chemoradiotherapy (cCHT plus RT) with or without induction docetaxel/cisplatin/5-fluorouracil (TPF) in locally advanced head and neck squamous cell carcinoma (LASCCHN): Preliminary results on toxicity of a randomized, 2x2 factorial, phase II-III study (NCT01086826)
Ghi, Maria Grazia
Paccagnella, Adriano
Ferrari, Daris
Foa, Paolo
Nole, Franco
Morelli, Franco
Azzarello, Giuseppe
D'Ambrosio, Consuelo
Casanova, Claudia
Guaraldi, Monica
Mantovani, Giovanni
Rossetto, Ciro
Bonetti, Andrea
Siena, Salvatore
Crino, Lucio
Buffoli, Alberto
Koussis, Haralabos
Pieri, Gabriella
Gava, Alessandro
Floriani, Irene
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)

← 1 →